VR Adviser as of March 31, 2025
Portfolio Holdings for VR Adviser
VR Adviser holds 37 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apogee Therapeutics (APGE) | 27.0 | $317M | 8.5M | 37.36 | |
| Mestera (MTSR) | 8.7 | $102M | 3.8M | 27.22 | |
| Ocular Therapeutix (OCUL) | 8.0 | $94M | 13M | 7.33 | |
| Enliven Therapeutics (ELVN) | 6.7 | $79M | 4.0M | 19.68 | |
| Kalvista Pharmaceuticals (KALV) | 6.6 | $77M | 6.7M | 11.54 | |
| Miragen Therapeutics (VRDN) | 4.5 | $52M | 3.9M | 13.48 | |
| Pharvaris N V (PHVS) | 4.2 | $49M | 3.1M | 15.70 | |
| Spyre Therapeutics Com New (SYRE) | 3.7 | $43M | 2.7M | 16.14 | |
| Oruka Therapeutics (ORKA) | 3.6 | $43M | 4.1M | 10.26 | |
| Praxis Precision Medicines I Com New (PRAX) | 3.2 | $38M | 990k | 37.87 | |
| Cogent Biosciences (COGT) | 2.9 | $34M | 5.7M | 5.99 | |
| Dianthus Therapeutics (DNTH) | 2.7 | $32M | 1.7M | 18.14 | |
| Dyne Therapeutics (DYN) | 1.9 | $23M | 2.2M | 10.46 | |
| Cidara Therapeutics Com New (CDTX) | 1.9 | $23M | 1.1M | 21.54 | |
| Engene Holdings (ENGN) | 1.9 | $23M | 5.0M | 4.48 | |
| Erasca (ERAS) | 1.9 | $22M | 16M | 1.37 | |
| Oric Pharmaceuticals (ORIC) | 1.5 | $18M | 3.2M | 5.58 | |
| Upstream Bio (UPB) | 1.2 | $14M | 2.3M | 6.12 | |
| Astria Therapeutics (ATXS) | 1.1 | $13M | 2.5M | 5.34 | |
| Cullinan Oncology (CGEM) | 0.9 | $10M | 1.4M | 7.57 | |
| Solid Biosciences Com New (SLDB) | 0.8 | $9.2M | 2.5M | 3.70 | |
| Savara (SVRA) | 0.8 | $9.0M | 3.3M | 2.77 | |
| Abivax Sa Sponsored Ads (ABVX) | 0.7 | $8.4M | 1.3M | 6.25 | |
| Perceptive Cap Solutions Cor Cl A Ord Shs (PCSC) | 0.7 | $7.7M | 750k | 10.30 | |
| Surrozen Com New (SRZN) | 0.6 | $7.4M | 633k | 11.66 | |
| Zura Bio Class A Ord Shs (ZURA) | 0.6 | $6.5M | 5.0M | 1.29 | |
| Artiva Biotherapeutics (ARTV) | 0.4 | $4.8M | 1.6M | 3.00 | |
| Trevi Therapeutics (TRVI) | 0.3 | $3.9M | 616k | 6.29 | |
| Applied Therapeutics (APLT) | 0.2 | $2.7M | 5.6M | 0.49 | |
| 4d Molecular Therapeutics In (FDMT) | 0.2 | $2.2M | 678k | 3.23 | |
| Casi Pharmaceuticals Ord Shs (CASI) | 0.2 | $2.1M | 987k | 2.16 | |
| Tenax Therapeutics Com New (TENX) | 0.1 | $1.4M | 208k | 6.55 | |
| Mersana Therapeutics | 0.1 | $1.2M | 3.6M | 0.34 | |
| Century Therapeutics (IPSC) | 0.1 | $1.2M | 2.5M | 0.48 | |
| Tenaya Therapeutics (TNYA) | 0.1 | $887k | 1.6M | 0.57 | |
| Glycomimetics | 0.1 | $630k | 3.0M | 0.21 | |
| Instil Bio Com New (TIL) | 0.0 | $576k | 33k | 17.36 |
